ResearcherTUM KlinikumActive in the last 2 years
Raphela A. Ranjan
Matched on ORCID iD 0000-0002-8519-0020; OpenAlex author ID A5040036122. Sources: OpenAlex.
Their work
- Papers
- 4
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 52
2020: 1 paper · 2021: 1 paper · 2022: none · 2023: none · 2024: none · 2025: 1 paper · 2026: 1 paper
Papers 4
- Modeling pancreatic cancer tumor stroma co-evolution in an in ovo model Co-author DOI 10.64898/2026.06.26.734719↗
- c-Rel drives pancreatic cancer metastasis through fibronectin-integrin signaling-induced isolation stress resistance and EMT. Co-author DOI 10.1186/s12943-025-02486-5↗
- Mesenchymal Plasticity Regulated by Prrx1 Drives Aggressive Pancreatic Cancer Biology. Co-author DOI 10.1053/j.gastro.2020.09.010↗
- Implementing cell-free DNA of pancreatic cancer patient-derived organoids for personalized oncology. Co-author DOI 10.1172/jci.insight.137809↗
Closest collaborators
The 25 strongest of 52 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Maximilian Reichert · 4 shared papers, 2020–2026 · strength 0.55
- Paper Modeling pancreatic cancer tumor stroma co-evolution in an in ovo model DOI 10.64898/2026.06.26.734719↗
- Paper c-Rel drives pancreatic cancer metastasis through fibronectin-integrin signaling-induced isolation stress resistance an… DOI 10.1186/s12943-025-02486-5↗
- Paper Mesenchymal Plasticity Regulated by Prrx1 Drives Aggressive Pancreatic Cancer Biology. DOI 10.1053/j.gastro.2020.09.010↗
- Roland Michael Schmid · 4 shared papers, 2020–2026 · strength 0.55
- Paper Modeling pancreatic cancer tumor stroma co-evolution in an in ovo model DOI 10.64898/2026.06.26.734719↗
- Paper c-Rel drives pancreatic cancer metastasis through fibronectin-integrin signaling-induced isolation stress resistance an… DOI 10.1186/s12943-025-02486-5↗
- Paper Mesenchymal Plasticity Regulated by Prrx1 Drives Aggressive Pancreatic Cancer Biology. DOI 10.1053/j.gastro.2020.09.010↗
- Roland Rad · 3 shared papers, 2020–2026 · strength 0.38
- Paper Modeling pancreatic cancer tumor stroma co-evolution in an in ovo model DOI 10.64898/2026.06.26.734719↗
- Paper Mesenchymal Plasticity Regulated by Prrx1 Drives Aggressive Pancreatic Cancer Biology. DOI 10.1053/j.gastro.2020.09.010↗
- Paper Implementing cell-free DNA of pancreatic cancer patient-derived organoids for personalized oncology. DOI 10.1172/jci.insight.137809↗
- Günter Schneider · 3 shared papers, 2020–2026 · strength 0.38
- Paper Modeling pancreatic cancer tumor stroma co-evolution in an in ovo model DOI 10.64898/2026.06.26.734719↗
- Paper Mesenchymal Plasticity Regulated by Prrx1 Drives Aggressive Pancreatic Cancer Biology. DOI 10.1053/j.gastro.2020.09.010↗
- Paper Implementing cell-free DNA of pancreatic cancer patient-derived organoids for personalized oncology. DOI 10.1172/jci.insight.137809↗
- Dieter Saur · 3 shared papers, 2020–2026 · strength 0.38
- Paper Modeling pancreatic cancer tumor stroma co-evolution in an in ovo model DOI 10.64898/2026.06.26.734719↗
- Paper Mesenchymal Plasticity Regulated by Prrx1 Drives Aggressive Pancreatic Cancer Biology. DOI 10.1053/j.gastro.2020.09.010↗
- Paper Implementing cell-free DNA of pancreatic cancer patient-derived organoids for personalized oncology. DOI 10.1172/jci.insight.137809↗
- Katja Peschke · 3 shared papers, 2020–2025 · strength 0.33
- Paper c-Rel drives pancreatic cancer metastasis through fibronectin-integrin signaling-induced isolation stress resistance an… DOI 10.1186/s12943-025-02486-5↗
- Paper Mesenchymal Plasticity Regulated by Prrx1 Drives Aggressive Pancreatic Cancer Biology. DOI 10.1053/j.gastro.2020.09.010↗
- Paper Implementing cell-free DNA of pancreatic cancer patient-derived organoids for personalized oncology. DOI 10.1172/jci.insight.137809↗
- H. Carlo Maurer · 2 shared papers, 2021–2026 · strength 0.31
- Hana Algül · 2 shared papers, 2020–2025 · strength 0.23
- Stefanie Bärthel · 1 shared paper, 2026 · strength 0.22
- Anna Melissa Schlitter · 1 shared paper, 2026 · strength 0.22
- Daniele Lucarelli · 1 shared paper, 2026 · strength 0.22
- Karin Feldmann · 2 shared papers, 2020–2021 · strength 0.17
- Wilko Weichert · 2 shared papers, 2020–2021 · strength 0.17
- Aristeidis Papargyriou · 2 shared papers, 2020–2021 · strength 0.17
- Zahra Dantes · 2 shared papers, 2020–2021 · strength 0.17
- Katrin J. Frank · 1 shared paper, 2025 · strength 0.16
- Jiaoyu Ai · 1 shared paper, 2025 · strength 0.16
- Derya Bakırdöğen · 1 shared paper, 2025 · strength 0.16
- Marina Lesina · 1 shared paper, 2025 · strength 0.16
- Kıvanç Görgülü · 1 shared paper, 2025 · strength 0.16
- María Jesús Fernández‐Aceñero · 1 shared paper, 2025 · strength 0.16
- Nan Wu · 1 shared paper, 2025 · strength 0.16
- Sonia Alcalá · 1 shared paper, 2025 · strength 0.16
- Harun Öztürk · 1 shared paper, 2025 · strength 0.16
- Juan Carlos López-Gil · 1 shared paper, 2025 · strength 0.16
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.